NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCTs021220023

Registered date:22/09/2022

Fluctuations in exhaled hydrogen gas due to oral administration of fructooligosaccharides

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedthreatened preterm birth
Date of first enrollment22/09/2022
Target sample size100
Countries of recruitment
Study typeInterventional
Intervention(s)Intake of fluctoligosaccharides

Outcome(s)

Primary Outcome1) Make healthy women take fluctoligosaccharides, assesment of increase experhal hydrogen and the degree 2) Make pregnant women take fluctoligosaccharides, assesment of increase experhal hydrogen and the degree
Secondary OutcomeEvaluation of side effects and other safety caused by fructooligosaccharide

Key inclusion & exclusion criteria

Age minimum>= 18age old
Age maximum< 50age old
GenderFemale
Include criteria1) Maternal age: 18 years old and over, under 50 years old 2) 50 healthy women without complications 3) 50 pregnant women who are planning to deliver at our department.
Exclude criteriaIf not gain consent

Related Information

Contact

Public contact
Name Hiroshi Miura
Address 44-2, Hasunuma, Hiro-omote, akita, akita Akita Japan 010-8543
Telephone +81-18-884-6163
E-mail miurah@doc.med.akita-u.ac.jp
Affiliation Akita University Hospital
Scientific contact
Name Hiroshi Miura
Address 44-2, Hasunuma, Hiro-omote, akita, akita Akita Japan 010-8543
Telephone +81-18-884-6163
E-mail miurah@doc.med.akita-u.ac.jp
Affiliation Akita University Hospital